Effect of oxygen therapy on myocardial salvage in ST elevation myocardial infarction: the randomized SOCCER trial

Ardavan Khoshnood1, Marcus Carlsson2, Mahin Akbarzadeh1

  • 1Department of Emergency and Internal Medicine.

Abstract

Insights

Supplemental oxygen did not improve outcomes in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). High-flow oxygen administration showed no significant difference in myocardial salvage or infarct size compared to room air in normoxic STEMI patients.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Medical Imaging

Background:

  • Emerging evidence suggests potential adverse effects of oxygen administration in acute myocardial infarction (AMI).
  • Optimal oxygen therapy for ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) remains under investigation.

Purpose of the Study:

  • To evaluate the impact of supplemental oxygen versus room air on myocardial salvage in STEMI patients undergoing PCI.
  • To assess infarct size and myocardium at risk using cardiac MRI (CMR) in this patient population.

Main Methods:

  • A randomized-controlled trial involving normoxic STEMI patients conducted at two Swedish university hospitals.
  • Patients were randomized in the ambulance to receive either high-flow oxygen (10 L/min) or room air until PCI completion.
  • Cardiac MRI was performed 2-6 days post-inclusion to assess myocardial salvage index, infarct size, and myocardium at risk.

Main Results:

  • No significant differences were observed in the myocardial salvage index between the oxygen group (53.9±25.1%) and the room air group (49.3±24.0%).
  • Myocardium at risk (31.9±10.0% vs. 30.0±11.8% of left ventricle) and infarct size (15.6±10.4% vs. 16.0±11.0% of left ventricle) were similar in both groups.
  • Patient characteristics at inclusion were comparable between the supplemental oxygen (n=46) and room air (n=49) groups.

Conclusions:

  • High-flow oxygen administration did not demonstrate a significant effect on myocardial salvage or infarct size in STEMI patients undergoing acute PCI.
  • These findings support the safety of withholding supplemental oxygen in normoxic STEMI patients.
  • The study contributes to understanding optimal oxygen management strategies in acute coronary syndromes.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
709
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
494
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
450